EAM
ALXO icon

Erste Asset Management’s ALX Oncology ALXO Stock Holding History

Erste Asset Management’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-9,200
Closed -$202K – 553
2021
Q4 		$202K Hold
9,200
– – ﹤0.01% 491
2021
Q3 		$675K Hold
9,200
– – 0.01% 375
2021
Q2 		$486K Hold
9,200
– – 0.01% 415
2021
Q1 		$629K Hold
9,200
– – 0.02% 374
2020
Q4 		$776K Buy
+9,200
New +$553K 0.02% 355

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Erste Asset Management's ALXO Position: Q1 2022 in Review

Erste Asset Management sold out of ALX Oncology (ALXO) in Q1 2022, closing a stake of 9,200 shares — an estimated $202K sold.

Erste Asset Management first reported a position in ALXO in Q4 2020 and held it in 5 quarters. The position peaked at $776K in Q4 2020. 96 funds tracked by Wall St. Rank hold ALXO as of Q1 2022.

  • Erste Asset Management reported no remaining ALX Oncology position as of Q1 2022 after selling out during the quarter.
  • Erste Asset Management sold 9,200 ALX Oncology shares in Q1 2022, an estimated $202K.
  • Erste Asset Management first reported a position in ALX Oncology in Q4 2020 and held it in 5 quarters.
  • Erste Asset Management's ALX Oncology position peaked at $776K in Q4 2020.
  • 96 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2022.

Based on Erste Asset Management's 13F filing for Q1 2022, filed 25 Nov 2024.